Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection.

Published in:

2022

By:

• Kieswetter, Nathan S.;
• Ozturk, Mumin;
• Hlaka, Lerato;
• Chia, Julius Ebua;
• Nichol, Ryan J. O.;
• Cross, Jasmine M.;
• McGee, Leah M. C.;
• Tyson-Hirst, Izaak;
• Beveridge, Rebecca;
• Brombacher, Frank;
• Carter, Katharine C.;
• Suckling, Colin J.;
• Scott, Fraser J.;
• Guler, Reto

Publication type:

journal article